All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Commentary
The joint development project by Alligator Bioscience and Aptevo Therapeutics, ALG.APV-527, shows potential in targeting solid tumours
By Tom Cohen |
17 January 2022
Bispecifics
Insight Article
In this Insight Article, we explore the future possibilities, challenges, and solutions in peptide purification and the delivery of precision medicine for immunotherapy.
By Tia Byer |
14 January 2022
Peptides
Post-Event Report
What are the key market trends and challenges facing the Peptides therapeutic industry today? We sat down with an advisory group of leading pharmaceutical and academic experts to discuss our latest Peptides Congress and the interesting insights it disclosed.
By Tia Byer |
12 January 2022
Peptides
Written Q&A
Strides made in a landmark phase IIb oral insulin clinical trial.
By Tom Cohen |
03 January 2022
Peptides
Commentary
Christine Rothe, Vice President of Early-Stage-Project Leadership and Data Science at Pieris Pharmaceuticals, presents a case study on Anticalin-antibody fusions for IO.
By Tia Byer |
08 December 2021
Proteins & Antibodies
Written Q&A
Could 'Small' Antibody Drug Conjugates Bring Big Advances in Solid Tumour Treatment?
By Tom Cohen |
06 December 2021
Proteins & Antibodies
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our October Discussion Group addressing ‘Analytical Method Development for Biotherapeutics’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
09 November 2021
Biologics Analysis
Commentary
Can biparatopic antibody-drug conjugates enhance cellular trafficking to cancerous tumours? William Olson of Regeneron finds out.
By Tia Byer |
01 November 2021
Proteins & Antibodies
Video Content
Webinar
Presented by Richard Blankley, Biopharma Application Specialist, Northern Europe, Agilent Technologies
21 October 2021
Biologics Analysis
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. The first of its kind, our September Discussion Group addressing ‘Antibody Discovery, Optimisation & Engineering’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
13 October 2021
Proteins & Antibodies

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login